PhilipHollingsworthImusMD

PubMed

• CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET.
  Ajay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, Gabriela Lofland, Ian Marsh, Dhiraj Kumar, Gabriel Ghiaur, Philip Imus, Steven P Rowe, Robert F Hobbs, Christian B G...> ;Advanced Science. 2024 Feb 29
• 2 citations
  Outpatient CD19-directed CAR T-cell therapy is feasible in patients of all ages.
  Andrew Ly, Khaled Sanber, Hua-Ling Tsai, Angela Ondo, Kathy Mooney, Audra Shedeck, Julie Baker, Philip Hollingsworth Imus, Nina Wagner-Johnston, Tania Jain> ;British Journal of Haematology. 2023 Nov 1
• 8 citations
  Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
  Amy E DeZern, Marianna Zahurak, Heather J Symons, Kenneth R Cooke, Carol Ann Huff, Tania Jain, Lode J Swinnen, Philip H Imus, Nina D Wagner-Johnston, Richard F Ambinde...> ;Blood. 2023 Jun 22
• Detection of an atypical BCR::ABL1 fusion in a patient with secondary B-cell acute lymphoblastic leukemia/lymphoma following multiple myeloma treatment.
  Karin Miller, Jonathan Webster, Philip Imus, Candice Ament, Melanie Hardy, Ying S Zou> ;Cancer Genetics. 2023 Jun 1
• 1 citations
  Clinical trial participation predicts improved survival in older adults receiving allogeneic blood and marrow transplant.
  Clifton P Thornton, Karen Bandeen-Roche, Madeline Dolinar, Laken C Roberts Lavigne, Dina George Lansey, Rick Jones, Jeremy Walston, Ravi Varadhan, Melissa Hladek, Phil...> ;BMC Geriatrics. 2023 Mar 4
• 1 citations
  Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years.
  Jonathan A Webster, Madison Reed, Hua-Ling Tsai, Alexander Ambinder, Tania Jain, Amy E Dezern, Mark J Levis, Margaret M Showel, Gabrielle T Prince, Christopher S Houri...> ;Transplantation and Cellular Therapy. 2023 Mar 1
• 1 citations
  Bone marrow niche chemoprotection of metastatic solid tumors mediated by CYP3A4.
  Gabriel Ghiaur, Kenneth C Valkenburg, Christopher Esteb, Alexander Ambinder, Philip H Imus, Kenneth J Pienta, Richard J Jones> ;Cancer. 2023 Jun 1
• 1 citations
  Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source.
  Cole H Sterling, Michael S Hughes, Hua-Ling Tsai, Kathryn Yarkony, Ephraim J Fuchs, Lode J Swinnen, Suman Paul, Javier Bolaños-Meade, Leo Luznik, Philip H Imus, Syed A...> ;Transplantation and Cellular Therapy. 2023 Apr 1
• 2 citations
  Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective study.
  Michael S Hughes, Cole H Sterling, Ravi Varadhan, Richard F Ambinder, Richard J Jones, Ronald J Sweren, Sima Rozati, Javier Bolaños-Meade, Leo Luznik, Philip H Imus, S...> ;Leukemia & Lymphoma. 2022 Dec 1
• 3 citations
  CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia.
  Brandy Perkins, Margaret Showel, Laura Schoch, Philip H Imus, Theodoros Karantanos, Raluca Yonescu, Laura Morsberger, Gabriel Ghiaur, Douglas E Gladstone, Richard J Jones> ;Leukemia & Lymphoma. 2022 Jul 1
• 11 citations
  Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibr...
  Tania Jain, Hua-Ling Tsai, Amy E DeZern, Lukasz P Gondek, Hany Elmariah, Javier Bolaños-Meade, Leonido Luznik, Ephraim Fuchs, Richard Ambinder, Douglas E Gladstone, Ph...> ;Transplantation and Cellular Therapy. 2022 May 1
• 9 citations
  Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma.
  Ross S Greenberg, Jake A Ruddy, Brian J Boyarsky, William A Werbel, Jacqueline M Garonzik-Wang, Dorry L Segev, Philip H Imus> ;BMC Cancer. 2021 Dec 27
• 5 citations
  Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide.
  Katherine Rappazzo, Marianna Zahurak, Maria Bettinotti, Syed Abbas Ali, Alexander J. Ambinder, Javier Bolaños-Meade, Ivan Borrello, Amy E. DeZern, Doug E Gladstone, Ch...> ;Transplantation and Cellular Therapy. 2021 Nov 1
• 7 citations
  An allogeneic multiple myeloma GM-CSF-secreting vaccine with lenalidomide induces long-term immunity and durable clinical responses in patients in near complete remission
  Luca Biavati, Carol Ann Huff, Anna Ferguson, Amy Sidorski, M Amanda Stevens, Lakshmi Rudraraju, Cristina Zucchinetti, Syed Abbas Ali, Philip H. Imus, Christian B. Gock...> ;Clinical Cancer Research. 2021 Oct 19
• 4 citations
  Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience.
  Alexander J. Ambinder, Matthew D. Smith, Hua-Ling Tsai, Ravi Varadhan, Amy E. DeZern, William Dalton, Christian B. Gocke, Jonathan Webster, Lukasz P. Gondek, Ivana Goj...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Oct 9
• 3 citations
  Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary ...
  Cole Sterling, Hua Ling Tsai, Matthias Holdhoff, Javier Bolaños-Meade, Leo Luznik, Ephraim J. Fuchs, Carol Ann Huff, Christian B. Gocke, Syed Abbas Ali, Ivan Borrello,...> ;Transplantation and Cellular Therapy. 2021 Oct 1
• 14 citations
  Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features.
  John-William Sidhom, Ingharan J. Siddarthan, Bo-Shiun Lai, Adam Luo, Bryan C. Hambley, Jennifer Bynum, Amy S. Duffield, Michael B. Streiff, Alison R. Moliterno, Philip...> ;NPJ Precision Oncology. 2021 May 14
• 5 citations
  Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
  Philip H. Imus, Hua Ling Tsai, Amy E. DeZern, Kevin Jerde, Lode J. Swinnen, Javier Bolaños-Meade, Leo Luznik, Ephraim J. Fuchs, Nina D. Wagner-Johnston, Carol Ann Huff...> ;Biology of Blood and Marrow Transplantation. 2020 Dec 1
• 66 citations
  CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity.
  Meisam Naeimi Kararoudi, Yuya Nagai, Ezgi Elmas, Marcelo de Souza Fernandes Pereira, Syed Abbas Ali, Philip H. Imus, Darren Wethington, Ivan Borrello, Dean A. Lee, Gab...> ;Blood. 2020 Nov 19
• 22 citations
  Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide.
  Jonathan Webster, Leo Luznik, Hua Ling Tsai, Philip H. Imus, Amy E. DeZern, Keith W. Pratz, Mark Levis, Ivana Gojo, Margaret M. Showel, Gabrielle T. Prince, Javier Bol...> ;Blood Advances. 2020 Oct 27
• 84 citations
  Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide.
  Amy E. DeZern, Marianna Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, Philip H. Imus, Ivan Borre...> ;Blood Advances. 2020 Apr 28
• 41 citations
  Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation
  Philip H. Imus, Amanda L. Blackford, Maria Bettinotti, Leo Luznik, Ephraim J. Fuchs, Carol Ann Huff, Douglas E. Gladstone, Richard F. Ambinder, Ivan Borrello, Robert J...> ;Biology of Blood and Marrow Transplantation. 2019 Dec 1
• 15 citations
  Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70.
  Philip H. Imus, Hua Ling Tsai, Leo Luznik, Ephraim J. Fuchs, Carol Ann Huff, Douglas E. Gladstone, Patrick Lowery, Richard F. Ambinder, Ivan Borrello, Lode J. Swinnen,...> ;Blood Advances. 2019 Sep 10
• 9 citations
  BCMA CAR T cells: the winding path to success
  Ivan Borrello, Philip H. Imus> ;The Journal of Clinical Investigation. 2019 Apr 29
• 41 citations
  Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide
  Laura K. Schoch, Kenneth R. Cooke, Nina D. Wagner-Johnston, Ivana Gojo, Lode J. Swinnen, Philip H. Imus, Ephraim J. Fuchs, Mark J. Levis, Richard F. Ambinder, Richard ...> ;Blood Advances. 2018 Sep 11
• Join now to see all

Abstracts/Posters

• Allogenic Stem Cell Transplantation for Secondary CNS Lymphoma: A Retrospective Review of 21 Patients
  Philip Hollingsworth Imus, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• CD38 Knockout Primary NK Cells to Prevent Fratricide and Boost Daratumumab Activity
  Philip Hollingsworth Imus, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019